Chemo Pharma Laboratories Inc Stock Price Today (NSE: CPL)
Fundamental Score
Chemo Pharma Laboratories Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Chemo Pharma Laboratories Inc share price today is ₹71.39, down 0.60% on NSE/BSE as of 17 June 2026. Chemo Pharma Laboratories Inc (CPL) is a Small-cap company in the Plastic Products - Industrial sector with a market capitalisation of ₹449.83 (Cr). The 52-week high for CPL share price is ₹87.75 and the 52-week low is ₹52.67. At a P/E ratio of 22.06x, CPL is currently trading below its industry average P/E of 23.37x. The company has a Return on Equity (ROE) of 15.41% and a debt-to-equity ratio of 0.48.
Chemo Pharma Laboratories Inc Share Price Chart — NSE/BSE Historical Performance
Chemo Pharma Laboratories Inc share price chart: -16.34% return over the past month. 52-week high ₹87.75, 52-week low ₹52.67.
Chemo Pharma Laboratories Inc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹74.00 | ₹74.96 | ₹72.30 | ₹73.03 | 49.45K (Cr) | |
| ₹78.40 | ₹78.40 | ₹74.11 | ₹74.93 | 67.39K (Cr) | |
| ₹79.36 | ₹79.36 | ₹76.10 | ₹76.46 | 30.87K (Cr) | |
| ₹78.20 | ₹79.50 | ₹78.00 | ₹78.96 | 43.12K (Cr) | |
| ₹80.00 | ₹80.79 | ₹76.22 | ₹79.76 | 81.66K (Cr) | |
| ₹82.00 | ₹82.30 | ₹78.90 | ₹79.35 | 96.40K (Cr) | |
| ₹76.50 | ₹80.85 | ₹76.15 | ₹80.09 | 2.29L (Cr) | |
| ₹77.90 | ₹77.90 | ₹76.02 | ₹76.87 | 67.75K (Cr) | |
| ₹78.88 | ₹78.88 | ₹76.03 | ₹77.23 | 1.11L (Cr) | |
| ₹77.74 | ₹79.64 | ₹76.96 | ₹78.86 | 44.78K (Cr) |
Chemo Pharma Laboratories Inc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹78.40 | ₹78.40 | ₹72.30 | ₹73.03 | -6.85% | |
| ₹85.20 | ₹87.47 | ₹75.70 | ₹76.46 | -10.26% | |
| ₹55.79 | ₹86.90 | ₹55.79 | ₹85.99 | +54.13% | |
| ₹71.00 | ₹71.00 | ₹52.67 | ₹54.25 | -23.59% | |
| ₹67.20 | ₹83.21 | ₹65.00 | ₹72.44 | +7.80% | |
| ₹80.80 | ₹83.90 | ₹65.00 | ₹65.63 | -18.77% | |
| ₹74.90 | ₹87.75 | ₹72.00 | ₹79.97 | +6.77% | |
| ₹77.18 | ₹83.00 | ₹68.50 | ₹74.90 | -2.95% | |
| ₹66.90 | ₹83.60 | ₹63.41 | ₹76.14 | +13.81% | |
| ₹68.00 | ₹70.00 | ₹58.41 | ₹65.78 | -3.26% | |
| ₹74.40 | ₹77.00 | ₹66.00 | ₹67.73 | -8.97% | |
| ₹77.20 | ₹86.10 | ₹71.10 | ₹73.02 | -5.41% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Micro-cap turnaround story built on hope and lacking concrete catalysts; steer clear unless you enjoy high-risk gambles.
WHAT'S HAPPENING NOW
No major catalysts found after live search. Recent news indicates general positive sentiment in the Indian plastics market, with events like PlastiWorld 2026 aiming to boost exports. India's Plastic Waste Management Rules were revised on March 31, 2026, focusing on a circular economy with mandatory recycled content and reuse targets.
CORE STORY
Chemo Pharma is a micro-cap play attempting a turnaround from pharmaceuticals to power and chemicals, leveraging existing cash resources. The market narrative is a high-risk, high-reward diversification strategy.
- Turnaround hopes
- Overall plastics sector growth
- Successful acquisition in power/chemicals
- Concrete order wins in new sectors
- Significant improvement in financial performance
- Micro/SME cap = liquidity risk
- Unproven management in new sectors
- Opacity around 'sick company' target
Promoter holding high at 69.08%, but down -0.29%. No FII/DII activity.
Indian plastic industry projected to grow, but Chemo Pharma's micro-cap status makes it vulnerable to sector-specific headwinds.
Poor. Free Cash Flow 5Y: ₹6.68 Cr
Next 3-6 months hinge on acquisition news. Without a concrete deal, expect the stock to drift downwards.
Primary Thesis Risk
Failure to execute diversification strategy will lead to value erosion.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Chemo Pharma Laboratories Inc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Chemo Pharma Laboratories Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CPL across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Return on Equity (15.41%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (16.37%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (38.11%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (49.70%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Balanced Promoter Holding (69.08%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Chemo Pharma Laboratories Inc vs Plastic Products - Industrial Peers
Peer Comparison - Plastic Products - Industrial
Compare Chemo Pharma Laboratories Inc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
39.2/100 | ₹71.39₹71 | ₹449.83₹449.83 | 22.06Average 22.1 Average | 15.41%Good 15.41% Good | 16.37%Good 16.37% Good | 0.48Excellent 0.5 Excellent | 8.40%Good 8.40% Good | 9.00%Good 9.00% Good | 0.00% | |
Supreme Industries LtdSupreme Industr... SUPREMEIND • 509930 | 53.6/100 | ₹3499.70₹3500 | ₹42365.85₹42365.85 | 49.96Average 50.0 Average | 17.14%Good 17.14% Good | 22.04%Excellent 22.04% Excellent | 0.06Excellent 0.1 Excellent | 14.56%Good 14.56% Good | 13.64%Good 13.64% Good | 1.02% |
Astral LimitedAstral Limited... ASTRAL • 532830 | 61.1/100 | ₹1526.00₹1526 | ₹38732.66₹38732.66 | 76.05Average 76.0 Average | 14.89%Average 14.89% Average | 19.71%Good 19.71% Good | 0.07Excellent 0.1 Excellent | 15.44%Excellent 15.44% Excellent | 17.74%Excellent 17.74% Excellent | 0.26% |
Shaily Engineering Plastics LtdShaily Engineer... SHAILY • 501423 | 43.6/100 | ₹3132.60₹3133 | ₹12031.71₹12031.71 | 82.32Average 82.3 Average | 18.49%Good 18.49% Good | 19.52%Good 19.52% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.08% |
Finolex Industries LtdFinolex Industr... FINPIPE • 500940 | 46.3/100 | ₹173.03₹173 | ₹10944.52₹10944.52 | 25.02Average 25.0 Average | 6.76%Poor 6.76% Poor | 8.77%Poor 8.77% Poor | 0.00Excellent 0.0 Excellent | 4.12%Average 4.12% Average | 6.77%Good 6.77% Good | 1.13% |
Time Technoplast LtdTime Technoplas... TIMETECHNO • 532856 | 52.7/100 | ₹172.03₹172 | ₹9836.32₹9836.32 | 23.37Average 23.4 Average | 14.22%Average 14.22% Average | 17.35%Good 17.35% Good | 0.22Excellent 0.2 Excellent | 18.02%Excellent 18.02% Excellent | 8.81%Good 8.81% Good | 0.63% |
Garware Hi Tech Films LtdGarware Hi Tech... GRWRHITECH • 500655 | 58.1/100 | ₹6225.00₹6225 | ₹8989.88₹8989.88 | 28.73Average 28.7 Average | 15.00%Good 15.00% Good | 20.57%Excellent 20.57% Excellent | 0.01Excellent 0.0 Excellent | 31.28%Excellent 31.28% Excellent | 17.93%Excellent 17.93% Excellent | 0.31% |
Kingfa Science & Technology Co, LtdKingfa Science ... KINGFA • 524019 | 60.3/100 | ₹5196.00₹5196 | ₹5906.41₹5906.41 | 37.51Average 37.5 Average | 23.21%Excellent 23.21% Excellent | 30.55%Excellent 30.55% Excellent | 0.01Excellent 0.0 Excellent | 44.08%Excellent 44.08% Excellent | 18.66%Excellent 18.66% Excellent | 0.00% |
Prince Pipes & Fittings LtdPrince Pipes & ... PRINCEPIPE • 542907 | 17.1/100 | ₹283.20₹283 | ₹3009.44₹3009.44 | 129.66Average 129.7 Average | 2.73%Poor 2.73% Poor | 3.85%Poor 3.85% Poor | 0.15Excellent 0.1 Excellent | -17.77%Poor -17.77% Poor | 9.06%Good 9.06% Good | 0.18% |
Jai Corp LtdJai Corp Ltd... JAICORPLTD • 512237 | 53.4/100 | ₹113.33₹113 | ₹2510.08₹2510.08 | 15.02Average 15.0 Average | 4.10%Poor 4.10% Poor | 4.18%Poor 4.18% Poor | 0.00Excellent 0.0 Excellent | 15.29%Excellent 15.29% Excellent | -0.35%Poor -0.35% Poor | 0.35% |
R M DRIP & SPRINK SYS LTDR M DRIP & SPRI... RMDRIP • 544456 | 60.6/100 | ₹16.05₹16 | ₹1978.13₹1978.13 | 62.94Average 62.9 Average | 39.70%Excellent 39.70% Excellent | 44.66%Excellent 44.66% Excellent | 0.41Excellent 0.4 Excellent | 53.59%Excellent 53.59% Excellent | 41.18%Excellent 41.18% Excellent | 0.06% |
Top Plastic Products - Industrial Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Supreme Industries Ltd share price42365.85 Cr
- Astral Limited share price38732.66 Cr
- Shaily Engineering Plastics Ltd share price12031.71 Cr
- Finolex Industries Ltd share price10944.52 Cr
- Time Technoplast Ltd share price9836.32 Cr
Chemo Pharma Laboratories Inc Quarterly Performance
Latest quarterly metrics for CPL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
49.70%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
38.11%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
9.00%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
8.40%
Compounded annual net profit growth over 5 years
Chemo Pharma Laboratories Inc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for CPL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Chemo Pharma Laboratories Inc Financial Statements
Annual income statement, balance sheet and cash flow for Chemo Pharma Laboratories Inc (CPL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Chemo Pharma Laboratories Inc
About CPL (Chemo Pharma Laboratories Inc)
Chemo Pharma Laboratories Inc is a dynamic force in the industrial plastic products sector, specializing in the creation of high-performance components and customized solutions for... diverse manufacturing needs. CPL distinguishes itself through a commitment to precision engineering, leveraging cutting-edge polymer science to develop robust, durable, and chemically resistant plastic products. Our core competency lies in the meticulous design and manufacturing of intricate plastic parts, ranging from specialized housings for sensitive equipment to vital components used in demanding industrial machinery. We collaborate closely with clients to understand their unique requirements, ensuring that our products seamlessly integrate into their existing systems and enhance operational efficiency. Driven by a deep understanding of material properties and manufacturing processes, CPL is dedicated to providing innovative solutions that optimize performance and reduce downtime. Our state-of-the-art facilities are equipped with advanced injection molding and extrusion technologies, enabling us to produce high-volume, consistent quality plastic parts that meet the strictest industry standards. We meticulously control every stage of the production process, from raw material selection to final inspection, ensuring that each component delivers exceptional performance in demanding industrial environments. Further, we pride ourselves on the ability to tailor our products to specific applications, offering a range of customization options including material selection, dimensions, and surface treatments. CPL stands as a reliable partner for businesses seeking dependable and innovative plastic product solutions. Our dedication to quality, combined with our focus on customer satisfaction, has established us as a preferred supplier for industrial clients across a range of sectors. We are constantly investing in research and development, exploring new materials and manufacturing techniques to stay at the forefront of the industry. Our unwavering commitment to excellence, combined with our collaborative approach to problem-solving, enables us to deliver customized solutions that exceed expectations and contribute to the success of our clients.
Company Details
Key Leadership
Corporate Events
Latest News
CPL Share Price: Frequently Asked Questions
What is the current share price of Chemo Pharma Laboratories Inc?
Chemo Pharma Laboratories Inc (CPL) trades at ₹71.39 on NSE and BSE. Market cap ₹449.83 (Cr). Educational data only.
What is the P/E ratio of Chemo Pharma Laboratories Inc?
Chemo Pharma Laboratories Inc has a P/E of 22.06x vs industry average 23.37x.
What is the Bull Run score for Chemo Pharma Laboratories Inc?
Chemo Pharma Laboratories Inc has a Bull Run score of 39.2/100 based on 25+ financial parameters.
Does Chemo Pharma Laboratories Inc pay dividends?
Chemo Pharma Laboratories Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Chemo Pharma Laboratories Inc?
Chemo Pharma Laboratories Inc has ROE of 15.41%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Chemo Pharma Laboratories Inc?
Chemo Pharma Laboratories Inc has debt-to-equity of 0.48.
Is Chemo Pharma Laboratories Inc a good investment?
Bull Run gives Chemo Pharma Laboratories Inc a score of 39.2/100. This is not investment advice — consult a SEBI-registered advisor.